Skip to content

Development and Application of an Early Oral Anti-inflammatory Diet Plan for Patients with Mild to Moderate Pancreatitis

Development and Application of an Early Oral Anti-inflammatory Diet Plan for Patients with Mild to Moderate Pancreatitis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094056
Enrollment
Unknown
Registered
2024-12-16
Start date
2024-12-16
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatitis

Interventions

Experimental Group :Experimental Group:The patients in this group will follow the prescribed anti-inflammatory diet plan.
Control Group:Control Group:The patients in this group will receive the department's routine nutritional management plan. Nutritional management and feeding will be based on the patients symptoms, suc

Sponsors

Mianyang Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with acute pancreatitis. 2.Patients classified as mild to moderate according to the revised Atlanta criteria, as determined by the physician (criteria details are shown in Tables 1 and 2). 3.Patients who voluntarily agree to participate in the study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1.Patients meeting any of the following conditions will be excluded:Known history of severe cardiovascular, respiratory, renal, gastrointestinal/liver, hematologic/tumor, or immune diseases, defined as: (1) Heart failure greater than New York Heart Association Class II. (2) Active myocardial ischemia. (3) Chronic kidney disease with serum creatinine greater than 2.0 mg/dL. (4) Chronic obstructive pulmonary disease requiring supplemental oxygen. (5) Gastrointestinal motility disorders or inflammatory bowel disease. (6) History of cirrhosis. (7) Active malignancies, except non-squamous skin cancer. 2.Exclusion of patients with a history of chronic pancreatitis or chronic pain syndrome in the 30 days prior to hospitalization, those requiring narcotic pain medications, or those who have been recently prescribed opioid drugs. Patients who have had abdominal surgery within the last 60 days will also be excluded. 3.Pregnant women. 4.Patients diagnosed with paralytic ileus by CT on admission. 5.Patients with concurrent cholangitis or cholecystitis.

Design outcomes

Primary

MeasureTime frame
inflammation biomarker;albumin;

Secondary

MeasureTime frame
intestinal flora;hospital stay;

Countries

China

Contacts

Public ContactHairong Lin

Mianyang Central Hospital

linhairongtianjin@163.com+86 153 8664 9325

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026